Olanzapine

NDC product · U.S. Food and Drug Administration (openFDA) · United States

  • Product NDC 39822-1800
  • Package NDC 39822-1800-1
  • Application number ANDA211072
  • SPL ID 4e3e841b-77b2-d902-e063-6294a90a9842
  • SPL set ID 3aad0f7b-8d0c-a9bf-e063-6394a90a6ae8
  • UNII N7U69T4SZR
  • RxCUI 485968

What the source publishes

Labeler
XGen Pharmaceuticals DJB, Inc.
Active ingredients
Olanzapine
Form
INJECTION, POWDER, FOR SOLUTION
Routes
INTRAMUSCULAR
Administrative status
present-in-source-snapshot
Marketing status
ANDA
Product type
HUMAN PRESCRIPTION DRUG
Prescription
Prescription or restricted

Names this record is found by

Complete source data
us:fda:ndc:39822-1800_4e3e841b-77b2-d902-e063-6294a90a9842
{
  "name": "Olanzapine",
  "splId": "4e3e841b-77b2-d902-e063-6294a90a9842",
  "labels": [
    {
      "setId": "3aad0f7b-8d0c-a9bf-e063-6394a90a6ae8",
      "labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=3aad0f7b-8d0c-a9bf-e063-6394a90a6ae8",
      "labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=3aad0f7b-8d0c-a9bf-e063-6394a90a6ae8"
    }
  ],
  "routes": [
    "INTRAMUSCULAR"
  ],
  "labeler": "XGen Pharmaceuticals DJB, Inc.",
  "finished": true,
  "packaging": [
    {
      "sample": false,
      "description": "1 VIAL in 1 CARTON (39822-1800-1)  / 2 mL in 1 VIAL",
      "package_ndc": "39822-1800-1",
      "identifierStatus": "well-formed",
      "marketing_start_date": "20250902"
    }
  ],
  "productId": "39822-1800_4e3e841b-77b2-d902-e063-6294a90a9842",
  "useDomain": "unknown",
  "dosageForm": "INJECTION, POWDER, FOR SOLUTION",
  "productNdc": "39822-1800",
  "deaSchedule": null,
  "genericName": "Olanzapine",
  "productType": "HUMAN PRESCRIPTION DRUG",
  "listingStatus": "present-in-source-snapshot",
  "targetSpecies": [],
  "approvalStatus": "not-established-by-ndc-listing",
  "labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
  "marketingEndDate": null,
  "activeIngredients": [
    {
      "name": "OLANZAPINE",
      "strength": "10 mg/2mL"
    }
  ],
  "applicationNumber": "ANDA211072",
  "marketingCategory": "ANDA",
  "stateRestrictions": {
    "status": "not-collected",
    "observations": []
  },
  "useDomainEvidence": {
    "basis": "unreviewed",
    "field": null,
    "value": null,
    "version": 1,
    "sourceId": "us.fda.ndc"
  },
  "marketingStartDate": "20250828",
  "targetSpeciesStatus": "not-reported",
  "prescriptionCategory": "prescription-or-restricted",
  "harmonizedIdentifiers": {
    "nui": [
      "N0000175430"
    ],
    "unii": [
      "N7U69T4SZR"
    ],
    "rxcui": [
      "485968"
    ],
    "spl_set_id": [
      "3aad0f7b-8d0c-a9bf-e063-6394a90a6ae8"
    ],
    "pharm_class_epc": [
      "Atypical Antipsychotic [EPC]"
    ],
    "manufacturer_name": [
      "XGen Pharmaceuticals DJB, Inc."
    ],
    "is_original_packager": [
      true
    ]
  },
  "listingExpirationDate": "20271231"
}

Read this record from your own software

The same record, with every field and its provenance, is one request away. An API key is free and works immediately.

GET /v1/drugs/record
curl -G "https://api.medifontis.com/v1/drugs/record" \
  -H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
  --data-urlencode "country=us" \
  --data-urlencode "sourceId=us.fda.ndc" \
  --data-urlencode "id=us:fda:ndc:39822-1800_4e3e841b-77b2-d902-e063-6294a90a9842"